Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
September 2009
September 1
'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of Evista in Romania
Neurobiological Technologies Announces Board Approval of Plan of Liquidation and Dissolution
September 2
BioDelivery Sciences to Consolidate Newark Operations and Bioral Amphotericin B Development at Raleigh Headquarters
Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.
FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML
Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation
Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices
September 3
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Akela Pharma announces restructuring
Algeta Signs $800 Million (EUR560m) Global Agreement With Bayer for Development and Commercialization of Alpharadin for Bone Metastases
BioMS Medical Provides Update on Dirucotide
Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive
Delcath Establishes Queensbury, NY Operations Facility
FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
Pfizer, Wyeth and Johnson & Johnson to Present at PharmaMed Marketing & Media Conference
Three Directors Set For Newly-Combined Merck
Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives
Blue Spoon Consulting Updates Briefing Note: ?Pharmaceutical Promotion At Its Productivity Frontier'
September 4
Elan Issues Statement Regarding Federal Court Ruling on Tysabri Collaboration Agreement
Carey & Danis LLC Announces Four Lawsuits Against the Makers of Levaquin
Tim Gunn Hosts Addressing Psoriasis Fashion Show to Raise Awareness of Psoriasis
Biogen Idec Announces Proposal to Acquire All Outstanding Shares of Facet for $14.50 per Share in Cash
September 8
Supply Plan of "Tamiflu" Anti-influenza Drug
Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government
Shire News: Update on velaglucerase alfa
Roche Announces New Corporate Executive Committee
Facet Biotech's Board of Directors Rejects Biogen Idec's Unsolicited Proposal as Inadequate
SEC Charges Seattle-Area Biotech Company With Fraudulently Hyping Stem Cell Breakthrough
September 9
September 10
Dynavax Reports FDA Removes Clinical Hold on HEPLISAV Phase 3 Hepatitis B Vaccine
Merck Updates Status of Clinical Development Programs for Investigational CGRP Receptor Antagonist Treatments for Acute Migraine; MK-3207 Clinical Development Discontinued
Marketing Exclusivity for First-in-Class Drugs Has Shortened to 2.5 Years
September 11
Alkermes Chairman Richard Pops to Resume Role of CEO
Mistrial Declared in First Federal Fosamax Trial
One-stop SEO Service Provider Delivers New Options to Strengthen Online Businesses
HPV Vaccine Study Shows Why Few Women Getting Shots
Roger Green and Associates (RG+A) announce DPS Tracker
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
September 14
September 15
Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010
Elan Cures Breach of Tysabri Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
78 percent of Americans see pharmaceutical industry deals as harmful
BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
Chicago Interactive Agency Marcel Media Wins HealthLeaders Media Marketing Award
Appeals Court Affirms Patent Infringement Rulings Against Roche's peg-EPO Product
September 16
September 17
FDA Sends Warning Letters to Allergan and Bioniche
FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
Wellcome Trust and Merck Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
Renovo - End of Offer Period & Restructuring
Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimer's Immunotherapy Program and Equity Investment
FDA Sends Warning Letter to Bioniche Pharma Over Sotradecol Web Pages
September 18
Pharmapalooza 2 Keeps the Beat Going Strong for Children's Health
ZymoGenetics Appoints Dennis M. Miller, Ph.D., Senior Vice President, Research and Preclinical Development
New Appointments at London Genetics to Drive Strategy Forward
Rite Aid Names Ernie Richardsen Group Vice President, Pharmaceutical Purchasing and Clinical Services
September 21
King Announces Commercial Availability of EMBEDA
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
Maxygen Announces Consummation of Joint Venture Transaction With Astellas
Biogen Idec Commences Tender Offer for Facet Biotech
September 22
David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
IMS Appoints Don Otterbein General Manager, Business Transformation Services, to Lead Expanded Knowledge Process Outsourcing Initiative
Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
MedWatch - Natalizumab (marketed as Tysabri) - FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML)
Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands
Appointment of Claude Bertrand as Executive Vice President, Chief Scientific Officer of Ipsen
Lilly Announces New U.S. Affiliate Leader
Health Industry Lobbyists Hosted at Least 130 Fundraisers for Members of Congressional Health Committees This Year
GSW Worldwide Announces New Members
ScienceFirst Staff Expansion
Mink Named President & CEO of ANGUS Chemical Company
Baer Consulting launches new division
Burnham Appoints Michael R. Jackson, Ph.D., Vice President for Drug Discovery & Development
September 23
CombinatoRx Stock Trading Halted Today; FDA Advisory Committees Meet to Discuss Exalgo
Janssen-Cilag's Stelara (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
LEO Pharma Repurchases Product Rights From Warner Chilcott
Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries
AB Research adds CRO veteran Daniel Menard to its management team as Canadian and Hungarian sites's activity climb to historical highs
Former FDA Commissioner Joins CHT
Semafore Retains Management Consulting Firm; Names Principal to Key Management Position
Aegis Adds Vice President of Sales
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
Michael Howe, Former CEO MinuteClinic, Joins MEDNETWorld Board of Directors
IGI Labs, Inc. Announces Narendra N. Borkar's Appointment to Its Board of Directors
U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014
ScienceFirst Staff Expansion
September 24
September 25
Pfizer and Eisai Continue Aricept Collaboration
Tamiflu (oseltamivir) for Oral Suspension: Medication Dosing Errors Reported
Eisai Announces Agreement with Pfizer on Strategic Alliance for Alzheimer's Disease Treatment Aricep
Frances D. Fergusson And John P. Mascotte Elected To Pfizer's Board Of Directors
Sitagliptin (marketed as Januvia and Janumet): Cases of acute pancreatitis reported
Heart Rhthym Society Taps Publicis Consultants
Merck Statement About JANUVIA (sitagliptin) and JANUMET (sitagliptin/metformin)
